Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
about
MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesmiRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.Measuring the Expression of microRNAs Regulated by Androgens.
P2860
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
@en
type
label
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
@en
prefLabel
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
@en
P2093
P2860
P356
P1433
P1476
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate
@en
P2093
Antti Kaipia
Harri Lähdesmäki
Janne Seppälä
Paula Kujala
Saara Lehmusvaara
Sanni Jalava
Teuvo L J Tammela
Timo Erkkilä
P2860
P304
P356
10.1002/PROS.22545
P577
2012-06-05T00:00:00Z